US Supreme Court urged to help speed up patient access to affordable generics

The US Generic Pharmaceutical Association (GPhA) and America’s Health Insurance Plans (AHIP) have filed an amicus brief urging the Supreme Court to preserve the inter partes review (IPR) process in promoting a competitive prescription drug market for consumers.

The associations’ support for the respondent in the case of Cuozzo v Lee addresses the critical role of the IPR, which protects consumers against abusive patent extensions.

The GPhA represents manufacturers and distributors of generics, while AHIP is the national trade association representing the health insurance industry.